Navigation Links
ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
Date:12/3/2008

RANCHO CORDOVA, Calif., Dec. 3 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that it will hold a conference call on Thursday, December 4, to discuss its announcement regarding a management transition at the Company.

The conference call will begin at 5:30 a.m., Pacific Standard Time (8:30 a.m., Eastern Standard Time). The call can be accessed by calling (800) 860-2422 (domestic) or (412) 858-4600 (international), passcode ThermoGenesis. The webcast will also be available on the Company's website at http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

A replay of the call will be available by calling (877) 344-7529 (domestic), or (412) 317-0088 (international), passcode 385107#, or via the Company's website.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

     ThermoGenesis Corp.
     Web site:http://www.thermogenesis.com
     Contact: Investor Relations
     +1-916-858-5107, or
     ir@thermogenesis.com

'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
2. ThermoGenesis Reports First Quarter 2009 Results
3. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
4. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
5. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
6. ThermoGenesis Corp. Reports First Quarter 2008 Results
7. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
8. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008
9. HMS Holdings Corp. To Present at The 20th Annual Piper Jaffray Healthcare Conference
10. Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing
11. HMS Holdings Corp. to Present at Stephens Inc. Fall Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: